Clinical Trial

The Role of Probiotic LH76 in Human Gut Health

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated May 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the safety and efficacy of the probiotic LH76 as a dietary supplement in healthy adults. The research will assess its effects on gut microbiota composition, intestinal health, and immune function compared to a placebo. Key outcomes include changes in microbial diversity, intestinal barrier integrity, and immune response markers over the intervention period. The findings will contribute to understanding the potential health benefits of LH76 and its role in supporting gut and immune health.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-08.
Trial Details
NCT Number NCT06875375
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Gut Microbiota Modulation
Enrollment 50 participants
Start Date 2025-05-11
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-10-26 (estimated)
Updated on ClinicalTrials.gov 2025-03-18